FlowMetric Diagnostics, Inc. Appoints Amy L. Williams as President

DOYLESTOWN, Pa.--()--FlowMetric Diagnostics, Inc., a diagnostic company developing advanced companion diagnostics from its flow cytometry platform, announces the appointment of Amy L. Williams as President effective September 1, 2014. In addition, Ms. Williams has joined the FlowMetric Diagnostics’ Board of Directors.

“As the FlowMetric brand grows and diversifies, Amy brings complementary skills and additional strategic insights to Ren Capocasale’s successful senior management team”

“Amy brings a wealth of experience to support our business and commercialization initiatives and will play a pivotal role in leading and executing our business strategy now and in the years ahead," said Ren Capocasale, Chairman of the Board, FlowMetric Diagnostics and CEO and founder of parent company, FlowMetric, Inc.

Ms. Williams has over 25 years of experience in the life science industry including publicly traded, equity backed and start-up companies. Prior to joining FlowMetric Diagnostics she was the President of SageWorks Rx, a consulting company to the life science industry. She has held a variety of commercial leadership roles at Merck and Endo Pharmaceuticals and has expertise in marketing, sales and reimbursement. Ms. Williams has extensive experience in launching new products and indications, creating and implementing contract reimbursement strategies and has developed the corporate positioning and strategy for a billion dollar publicly traded organization.

“As the FlowMetric brand grows and diversifies, Amy brings complementary skills and additional strategic insights to Ren Capocasale’s successful senior management team,” added Christopher P. Molineaux, President & CEO of Pennsylvania Bio. “I am pleased and excited to be given this opportunity to lead FlowMetric Diagnostics; it is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalized medicine and better meet the needs of physicians, healthcare workers and patients,” said Williams. “This is an exciting time for the company and I am thrilled to be joining the FlowMetric Diagnostics team.”

About FlowMetric Diagnostics, Inc.

FlowMetric Diagnostics, Inc., is an affiliate company to FlowMetric Inc., and is developing advanced companion diagnostics from its flow cytometry platform. The company is planning to establish a state-of-the-art FDA-compliant Flow Cytometry laboratory in which to perform CLIA-certified diagnostic tests from both the company’s own assay portfolio as well as those of partnering diagnostic companies. For more information, visit www.flowmetricdiagnostics.com.

Contacts

FlowMetric Diagnostics, Inc.
Dina Melagrana, 267-893-6745
info@flowmetricdiagnostics.com
www.flowmetricdiagnostics.com

Website

Release Summary

Announcing Amy Williams as President of FlowMetric Diagnostics

FlowMetric Diagnostics, Inc.